Financier aims to attract foreign investors to Danish biotech companies
Wealthy foreigners are keen on investing in promising Danish life science companies. This is according to Martin Rasmussen, who has 25 years of experience in London's investment banks and convinced a British family to invest in Copenhagen-based Immunitrack.
When Danish biotech company and CRO Immunitrack received a million investment in May this year, the money came from an unknown wealthy Londoner whose key competence is actually not life science.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
